HF
UNCY icon

HRT Financial’s Unicycive Therapeutics UNCY Stock Holding History

HRT Financial’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$273K Buy
+41,492
New +$272K ﹤0.01% 2951
2025
Q2 		– Sell
-1,782
Closed -$10K – 3559
2025
Q1 		$10K Sell
1,782
-431
-19% -$2.63K ﹤0.01% 2354
2024
Q4 		$17K Buy
+2,213
New +$12.3K ﹤0.01% 2227

Other funds holding UNCY

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial's UNCY Position: Q1 2026 in Review

HRT Financial opened a new position in Unicycive Therapeutics (UNCY) in Q1 2026: 41,492 shares worth $273K. The stake represents ﹤0.01% of the portfolio and ranks #2951 among its holdings. This is a return to the name: HRT Financial previously reported a position in UNCY as recently as Q1 2025.

HRT Financial first reported a position in UNCY in Q4 2024 and has held it in 3 quarters since. 51 funds tracked by Wall St. Rank hold UNCY as of Q1 2026.

  • HRT Financial held 41,492 shares of Unicycive Therapeutics worth $273K as of Q1 2026.
  • Unicycive Therapeutics was a new HRT Financial position in Q1 2026.
  • Unicycive Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #2951 holding.
  • HRT Financial first reported a position in Unicycive Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • 51 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.